A detailed history of Beese Fulmer Investment Management, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 4,391 shares of ZTS stock, worth $761,794. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,391
Previous 4,820 8.9%
Holding current value
$761,794
Previous $815,000 6.63%
% of portfolio
0.07%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

SELL
$145.54 - $178.83 $62,436 - $76,718
-429 Reduced 8.9%
4,391 $761,000
Q1 2024

Apr 08, 2024

SELL
$165.67 - $199.94 $6,626 - $7,997
-40 Reduced 0.82%
4,820 $815,000
Q4 2023

Jan 09, 2024

BUY
$151.44 - $200.09 $1,817 - $2,401
12 Added 0.25%
4,860 $959,000
Q1 2023

Apr 11, 2023

SELL
$145.48 - $175.02 $51,645 - $62,132
-355 Reduced 6.82%
4,848 $806,000
Q4 2022

Jan 17, 2023

SELL
$131.14 - $157.47 $9,310 - $11,180
-71 Reduced 1.35%
5,203 $0
Q2 2022

Jul 11, 2022

SELL
$155.97 - $200.09 $26,046 - $33,415
-167 Reduced 3.07%
5,274 $907,000
Q1 2022

Apr 12, 2022

SELL
$181.39 - $234.03 $42,445 - $54,763
-234 Reduced 4.12%
5,441 $1.03 Million
Q4 2021

Jan 10, 2022

BUY
$193.69 - $247.03 $19,369 - $24,703
100 Added 1.79%
5,675 $1.39 Million
Q3 2021

Oct 08, 2021

BUY
$189.29 - $209.69 $18,929 - $20,969
100 Added 1.83%
5,575 $1.08 Million
Q2 2021

Jul 08, 2021

SELL
$155.9 - $187.99 $73,428 - $88,543
-471 Reduced 7.92%
5,475 $1.02 Million
Q1 2020

Apr 09, 2020

SELL
$92.66 - $144.94 $6,949 - $10,870
-75 Reduced 1.25%
5,946 $700,000
Q2 2019

Jul 05, 2019

SELL
$97.98 - $114.28 $11,659 - $13,599
-119 Reduced 1.94%
6,021 $683,000
Q4 2017

Jan 26, 2018

SELL
$63.24 - $72.8 $6,134 - $7,061
-97 Reduced 1.56%
6,140 $442,000
Q3 2017

Oct 17, 2017

BUY
$59.73 - $65.4 $372,536 - $407,899
6,237
6,237 $398,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Beese Fulmer Investment Management, Inc. Portfolio

Follow Beese Fulmer Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.